Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer

Amit Sud, Michael Jones, John Broggio, Stephen Scott, Chey Loveday, Bethany Torr, Alice Garrett, David L. Nicol, Shaman Jhanji, Stephen A. Boyce, Matthew Williams, Georgios Lyratzopoulos, Claire Barry, Elio Riboli, Emma Kipps, Ethna McFerran, Mark Lawler, David C. Muller, Muti Abulafi, Richard Houlston, Clare Turnbull
doi: https://doi.org/10.1101/2020.04.28.20083170

Article Information

doi 
https://doi.org/10.1101/2020.04.28.20083170
History 
  • May 5, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Amit Sud1,*,
  2. Michael Jones1,*,
  3. John Broggio2,*,
  4. Stephen Scott3,*,
  5. Chey Loveday1,
  6. Bethany Torr1,
  7. Alice Garrett1,
  8. David L. Nicol4,5,
  9. Shaman Jhanji6,7,
  10. Stephen A. Boyce8,
  11. Matthew Williams9,10,
  12. Georgios Lyratzopoulos2,11,
  13. Claire Barry3,
  14. Elio Riboli12,
  15. Emma Kipps3,13,
  16. Ethna McFerran14,
  17. Mark Lawler14,
  18. David C. Muller12,
  19. Muti Abulafi15,
  20. Richard Houlston1,16 and
  21. Clare Turnbull1,2,16,†
  1. 1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
  2. 2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
  3. 3RM Partners, West London Cancer Alliance, London, UK
  4. 4Urology Unit, Royal Marsden NHS Foundation Trust, London, UK
  5. 5Department of Clinical Studies, Institute of Cancer Research, London, UK
  6. 6Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London, UK
  7. 7Division of Cancer Biology, Institute of Cancer Research, London, UK
  8. 8Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
  9. 9Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK
  10. 10Computational Oncology Group, Imperial College London, London, UK
  11. 11Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, University College London, London, UK
  12. 12School of Public Health, Imperial College London
  13. 13The Breast Unit, Royal Marsden NHS Foundation Trust, London, UK
  14. 14Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast
  15. 15Colorectal Surgery, Croydon Health Services NHS Trust, on behalf of RMP NICE FIT Steering Group
  16. 16Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK
  1. ↵†Corresponding author: Clare Turnbull; address: Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK, SM2 5NG; email: Clare.Turnbull{at}icr.ac.uk; tel: 020 8722 4487.

  1. ↵* These authors contributed equally to the work

Back to top
Posted May 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Quantifying and mitigating the impact of the COVID-19 pandemic on outcomes in colorectal cancer
Amit Sud, Michael Jones, John Broggio, Stephen Scott, Chey Loveday, Bethany Torr, Alice Garrett, David L. Nicol, Shaman Jhanji, Stephen A. Boyce, Matthew Williams, Georgios Lyratzopoulos, Claire Barry, Elio Riboli, Emma Kipps, Ethna McFerran, Mark Lawler, David C. Muller, Muti Abulafi, Richard Houlston, Clare Turnbull
medRxiv 2020.04.28.20083170; doi: https://doi.org/10.1101/2020.04.28.20083170
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area